[Current status of chemotherapy of advanced gastrointestinal tumors].
Gan No Rinsho
; 32(10): 1089-94, 1986 Aug.
Article
en Ja
| MEDLINE
| ID: mdl-3537357
In general, progress of chemotherapy for advanced gastrointestinal tumors has been slow, however, introduction of cisplatin has improved the results of chemotherapy in esophageal cancer. Cisplatin has been also recognized to be active for gastric cancer and study of combinations containing it is underway. Adriamycin appears to be the most active for hepatoma and 5-fluorouracil for pancreatic and colorectal cancers. Thus, combinations containing these drugs have been extensively studied but none has shown a definitive superiority over single agent efficacy of both drugs.
Buscar en Google
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Protocolos de Quimioterapia Combinada Antineoplásica
/
Neoplasias del Sistema Digestivo
Límite:
Humans
Idioma:
Ja
Revista:
Gan No Rinsho
Año:
1986
Tipo del documento:
Article
Pais de publicación:
Japón